# Association of Survival With Maintenance Therapy in Patients With Metastatic Breast Cancer After First-line Chemotherapy

> **NCT04258163** · — · COMPLETED · sponsor: **Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University** · enrollment: 760 (actual)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **DRUG:** Capecitabine
- **DRUG:** Liposomal doxorubicin
- **DRUG:** Gemcitabine
- **DRUG:** Fulvestrant
- **DRUG:** Anastrozole
- **DRUG:** Letrozole

## Key facts

- **NCT ID:** NCT04258163
- **Lead sponsor:** Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2019-06-01
- **Final completion:** 2019-07-01
- **Target enrollment:** 760 (ACTUAL)
- **Last updated:** 2020-02-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04258163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04258163, "Association of Survival With Maintenance Therapy in Patients With Metastatic Breast Cancer After First-line Chemotherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04258163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*